$SEPN

Septerna (SEPN) awards CMO 275,000 options at $37.37

Septerna (SEPN) disclosed that its CMO, Rajiv Patni, received 275,000 stock options on September 8, 2026, with an exercise price of $37.37 per share. The options expire on September 7, 2036, with 25% vesting on August 24, 2027, and the remainder in monthly installments over three years, contingent on his continued service.

Original reporting
Published Sep 10, 2026, 9:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 11, 2026, 1:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$SEPN
Neutral
high confidence
Mentioned
$SEPN
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$SEPNNeutralLow
01

Why it matters

The grant adds 275,000 options at $37.37 exercise price, vesting over 36 months, with no immediate cash flow impact.

02

Market read

Limited relevance; primarily of interest to existing shareholders and insiders.

03

What to watch

Potential future dilution if options are exercised; monitor subsequent insider activity.

Relevance 4/10Novelty 3/10Timing: effective September 8, 2026

Background

Form 4 filing reporting an equity compensation grant to a senior executive.

Company-level read

Ticker impact

$SEPNNeutralHigh confidence
Context

Septerna disclosed a grant of 275,000 stock options to its CMO Rajiv Patni, vesting over 36 months.

Expected impact

minimal effect, likely negligible on share price

Evidence & confidence

The grant size is modest relative to market cap and no cash transaction occurred.

Market effects

None; the grant is specific to Septerna and does not affect the broader biotech sector.

None; limited to the company's shareholders.

None

Counterpoint

Even small insider grants can signal confidence; some investors may view it positively.

Key entities

  • Septerna, Inc.

    Biotech company issuing the options.

  • Rajiv Patni

    Chief Medical Officer receiving the option grant.

Related articles

$SEPNMed

Septerna Highlights Business Progress and Reports Second Quarter 2026 Financial Results

Septerna, Inc. (SEPN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Septerna Highlights Business Progress and Reports Second Quarter 2026 Financial Results Phase 1 Clinical Trial Ongoing for SEP-479, an Oral Small Molecule PTH1R Agonist SEP-479 Observed Clinical Pharmacokinetic Profile Supports Once-Daily Dosing; SAD / MAD Data Expec

$MANMed

Milwaukee-based Manpower names first new CEO in more than 12 years

ManpowerGroup (MAN) appoints Becky Frankiewicz as CEO effective January 1, succeeding Jonas Prising. Frankiewicz, currently president and chief strategy officer, will be the fifth CEO in the company's history. The firm reported a $13.3M loss on $18B revenue in 2025. Prising transitions to executive chair. Frankiewicz led AI integration and North American operations.

$AAPLMed

OpenAI Makes a Serious Allegation Involving Apple

OpenAI alleges a former employee, now at Apple (AAPL), transferred 100+ files related to an unreleased product to a personal account before presenting it to Apple's leadership, potentially influencing Apple's AI hardware development. Apple denies the claims, stating it has policies to prevent such use of confidential information and found no evidence supporting OpenAI's allegations. The dispute is part of an ongoing trade-secret case between the two companies.

$FRMIMed

Fermi details $6.5 billion, 15-year TensorWave lease for 222 MW at Project Matador

Fermi (FRMI) announced a 15-year lease with TensorWave for 222 MW at Project Matador, Texas. The deal, valued at $6.5 billion, includes 2.5% annual escalators and renewal options. Fermi will develop and build the facility, with occupancy starting in Q4 2027. Estimated capex ranges from $666 million to $888 million for power and $1.56 billion to $1.87 billion for the data center. The lease is expected to close by October 31, with AMD providing credit support.